Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2024-04-30 00:00:00 ET · period of report 2024-04-26 · accession 0001415889-24-011764 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-30 | 2024-04-26 | KNSA | Ragosa Mark | CFO | F - Tax | $17.88 | -509 | 19.3K | -3% | -$9,101 |
| D | 2024-04-30 | 2024-04-26 | KNSA | Ragosa Mark | CFO | M - OptEx | — | +991 | 19.8K | +5% | — |
| D | 2024-04-30 | 2024-04-26 | KNSA | Ragosa Mark | CFO | M - OptEx | $0.00 | +991 | 990 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Share | 2024-04-26 | F | D | 509 | $17.88 | 19,253 | D | — | — | |
| 2 | Common | Class A Common Share | 2024-04-26 | M | A | 991 | — | 19,762 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. |
| 3 | Derivative | Restricted Share Unit | 2024-04-26 | M | A | 991 | $0.00 | 990 | D | — · — to — | 991 Class A Common Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. (F2) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 26, 2021. |